Cargando…

Prostate specific membrane antigen (PSMA) expression in non-small cell lung cancer

OBJECTIVES: PSMA (prostate-specific membrane antigen) is overexpressed in prostate cancer cells and is reported to be a promising target for antibody-based radioligand therapy in patients with metastasized prostate cancer. Since PSMA expression is not restricted to prostate cancer, the underlying st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schmidt, Lars Henning, Heitkötter, Birthe, Schulze, Arik B., Schliemann, Christoph, Steinestel, Konrad, Trautmann, Marcel, Marra, Alessandro, Hillejan, Ludger, Mohr, Michael, Evers, Georg, Wardelmann, Eva, Rahbar, Kambiz, Görlich, Dennis, Lenz, Georg, Berdel, Wolfgang E., Hartmann, Wolfgang, Wiewrodt, Rainer, Huss, Sebastian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5659610/ https://www.ncbi.nlm.nih.gov/pubmed/29077706 http://dx.doi.org/10.1371/journal.pone.0186280

Ejemplares similares

Expression of PSMA in tumor neovasculature of high grade sarcomas including synovial sarcoma, rhabdomyosarcoma, undifferentiated sarcoma and MPNST
por: Heitkötter, Birthe, et al.
Publicado: (2016)

Neovascular PSMA expression is a common feature in malignant neoplasms of the thyroid
por: Heitkötter, Birthe, et al.
Publicado: (2018)

Tumor infiltrating T cells influence prognosis in stage I–III non-small cell lung cancer
por: Schulze, Arik Bernard, et al.
Publicado: (2020)

Prognostic impact of CD34 and SMA in cancer‐associated fibroblasts in stage I–III NSCLC
por: Schulze, Arik Bernard, et al.
Publicado: (2019)

Potential therapeutic impact of CD13 expression in non-small cell lung cancer
por: Schmidt, Lars Henning, et al.
Publicado: (2017)

Correction: Potential therapeutic impact of CD13 expression in non-small cell lung cancer
por: Schmidt, Lars Henning, et al.
Publicado: (2017)

High Expression of NT5DC2 Is a Negative Prognostic Marker in Pulmonary Adenocarcinoma
por: Schulze, Arik Bernard, et al.
Publicado: (2022)

Future Options of Molecular-Targeted Therapy in Small Cell Lung Cancer
por: Schulze, Arik Bernard, et al.
Publicado: (2019)

Neovascular Prostate-Specific Membrane Antigen Expression Is Associated with Improved Overall Survival under Palliative Chemotherapy in Patients with Pancreatic Ductal Adenocarcinoma
por: Stock, Katharina, et al.
Publicado: (2017)

High expression of transcription factor POU2F1 confers improved survival on smokers with lung adenocarcinoma: a retrospective study of two cohorts
por: Schulze, Arik Bernard, et al.
Publicado: (2023)

Central airway obstruction treatment with self‐expanding covered Y‐carina nitinol stents: A single center retrospective analysis
por: Schulze, Arik Bernard, et al.
Publicado: (2022)

PD-1 and PD-L1 Expression in NSCLC Indicate a Favorable Prognosis in Defined Subgroups
por: Schmidt, Lars Henning, et al.
Publicado: (2015)

Thoracic Malignancies and Pulmonary Nodules in Patients under Evaluation for Transcatheter Aortic Valve Implantation (TAVI): Incidence, Follow Up and Possible Impact on Treatment Decision
por: Schmidt, Lars Henning, et al.
Publicado: (2016)

Mutations of the EPHB6 Receptor Tyrosine Kinase Induce a Pro-Metastatic Phenotype in Non-Small Cell Lung Cancer
por: Bulk, Etmar, et al.
Publicado: (2012)

Alpha-1 Antitrypsin Deficiency and Pulmonary Morbidity in Patients with Primary Immunodeficiency Disease: A Single-Center Experience
por: Evers, Georg, et al.
Publicado: (2020)

Multiparametric Magnetic Resonance Imaging for Immediate Target Hit Assessment of CD13—Targeted Tissue Factor tTF-NGR in Advanced Malignant Disease
por: Gerwing, Mirjam, et al.
Publicado: (2021)

Bronchoscopist-Directed Continuous Flow Propofol Based Analgosedation during Flexible Interventional Bronchoscopy and EBUS
por: Evers, Georg, et al.
Publicado: (2023)

Radiomics of Tumor Heterogeneity in (18)F-FDG-PET-CT for Predicting Response to Immune Checkpoint Inhibition in Therapy-Naïve Patients with Advanced Non-Small-Cell Lung Cancer
por: Ventura, David, et al.
Publicado: (2023)

Diagnostic tools in the differential diagnosis of giant cell-rich lesions of bone at biopsy
por: Rehkämper, Jan, et al.
Publicado: (2018)

Aminopeptidase N (CD13): Expression, Prognostic Impact, and Use as Therapeutic Target for Tissue Factor Induced Tumor Vascular Infarction in Soft Tissue Sarcoma
por: Kessler, Torsten, et al.
Publicado: (2018)

Adjuvant chemotherapy—Radiotherapy—Chemotherapy sandwich protocol in resectable soft tissue sarcoma: An updated single-center analysis of 104 cases
por: Schliemann, Christoph, et al.
Publicado: (2018)

Evaluation of (68)Ga-PSMA-11 PET-MRI in Patients with Advanced Prostate Cancer Receiving (177)Lu-PSMA-617 Therapy: A Radiomics Analysis
por: Roll, Wolfgang, et al.
Publicado: (2021)

PSMA Theranostics: Current Status and Future Directions
por: Rahbar, Kambiz, et al.
Publicado: (2018)

Prognostic factors of resected node-positive lung cancer: location, extent of nodal metastases, and multimodal treatment
por: Marra, Alessandro, et al.
Publicado: (2011)

Magnesium levels and outcome after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia
por: Angenendt, Linus, et al.
Publicado: (2020)

Time after Synthesis and Time after Injection Do Not Affect Diagnostic Quality of [(18)F]F-PSMA 1007 PET
por: Relt, Elisabeth, et al.
Publicado: (2022)

Regulators of Actin Dynamics in Gastrointestinal Tract Tumors
por: Steinestel, Konrad, et al.
Publicado: (2015)

Combinatorial effects of doxorubicin and retargeted tissue factor by intratumoral entrapment of doxorubicin and proapoptotic increase of tumor vascular infarction
por: Stucke-Ring, Janine, et al.
Publicado: (2016)

Lutetium-177 Labelled PSMA Targeted Therapy in Advanced Prostate Cancer: Current Status and Future Perspectives
por: Seitzer, Konstantin Egon, et al.
Publicado: (2021)

Sustained Impairment in Cardiopulmonary Exercise Capacity Testing in Patients after COVID-19: A Single Center Experience
por: Evers, Georg, et al.
Publicado: (2022)

Polyclonal on- and off-target resistance mutations in an EML4-ALK positive non-small cell lung cancer patient under ALK inhibition
por: Kemper, Marcel, et al.
Publicado: (2021)

Addendum: Polyclonal on- and off-target resistance mutations in an EML4-ALK positive non-small cell lung cancer patient under ALK inhibition
por: Kemper, Marcel, et al.
Publicado: (2022)

Total tumor volume reduction and low PSMA expression in patients receiving Lu-PSMA therapy
por: Seifert, Robert, et al.
Publicado: (2021)

Risk Factors in HIV-1 Positive Patients on the Intensive Care Unit: A Single Center Experience from a Tertiary Care Hospital
por: Schulze, Arik Bernard, et al.
Publicado: (2023)

Progressive Multifocal Leukoencephalopathy after Ibrutinib Therapy for Chronic Lymphocytic Leukemia
por: Lutz, Mathias, et al.
Publicado: (2017)

Liquid Biopsies in Lung Cancer
por: Kemper, Marcel, et al.
Publicado: (2023)

Expression levels of hnRNP K and p21(WAF1/CIP1 )are associated with resistance to radiochemotherapy independent of p53 pathway activation in rectal adenocarcinoma
por: Daskalaki, Wassiliki, et al.
Publicado: (2018)

Rapid response to systemic bevacizumab therapy in recurrent respiratory papillomatosis
por: MOHR, MICHAEL, et al.
Publicado: (2014)

Overexpression and Tyr421-phosphorylation of cortactin is induced by three-dimensional spheroid culturing and contributes to migration and invasion of pancreatic ductal adenocarcinoma (PDAC) cells
por: Stock, Katharina, et al.
Publicado: (2019)

Novel pathogenic alterations in pediatric and adult desmoid-type fibromatosis – A systematic analysis of 204 cases
por: Trautmann, Marcel, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_mhbo40q11sdpeh319tbt1vp3ct